Transthera Sciences FY26 H1 net loss narrows to RMB 95.47 million; revenue rises to RMB 35.46 million

• Transthera Sciences posted a net loss of RMB 95.47 million, narrowing from RMB 122.87 million a year earlier.
• Revenue was RMB 35.46 million, compared with no revenue a year earlier, driven by a one-time licensing upfront payment.
• Research and development costs rose 11.7% to RMB 109.93 million, while administrative expenses fell 16.1% to RMB 23.06 million.
• Other income climbed to RMB 13.98 million from RMB 986,000 on higher bank interest income and government grants.
• Net foreign-exchange loss widened to RMB 11.65 million from RMB 396,000, reflecting a weaker US dollar versus the RMB.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transthera Sciences (Nanjing) Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260826-12300311), on August 26, 2026, and is solely responsible for the information contained therein.